Cargando…
The Value of OCT and OCTA as Potential Biomarkers for Preclinical Alzheimer’s Disease: A Review Study
Preclinical Alzheimer’s disease (AD) includes cognitively healthy subjects with at least one positive biomarker: reduction in cerebrospinal fluid Aβ(42) or visualization of cerebral amyloidosis by positron emission tomography imaging. The use of these biomarkers is expensive, invasive, and not alway...
Autores principales: | López-Cuenca, Inés, Salobrar-García, Elena, Elvira-Hurtado, Lorena, Fernández-Albarral, José A., Sánchez-Puebla, Lidia, Salazar, Juan J., Ramírez, José M., Ramírez, Ana I., de Hoz, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306512/ https://www.ncbi.nlm.nih.gov/pubmed/34357083 http://dx.doi.org/10.3390/life11070712 |
Ejemplares similares
-
Retinal Vascular Study Using OCTA in Subjects at High Genetic Risk of Developing Alzheimer’s Disease and Cardiovascular Risk Factors
por: López-Cuenca, Inés, et al.
Publicado: (2022) -
Macular Thickness Decrease in Asymptomatic Subjects at High Genetic Risk of Developing Alzheimer’s Disease: An OCT Study
por: López-Cuenca, Inés, et al.
Publicado: (2020) -
Characterization of Retinal Drusen in Subjects at High Genetic Risk of Developing Sporadic Alzheimer’s Disease: An Exploratory Analysis
por: López-Cuenca, Inés, et al.
Publicado: (2022) -
Alzheimer’s disease: a continuum with visual involvements
por: Elvira-Hurtado, Lorena, et al.
Publicado: (2023) -
Exploratory Longitudinal Study of Ocular Structural and Visual Functional Changes in Subjects at High Genetic Risk of Developing Alzheimer’s Disease
por: López-Cuenca, Inés, et al.
Publicado: (2023)